Xie Yi
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Extrawell Phar | 00858 | 02-Jul-12 | 01-Jan-26 | CEO | For the purposes of segregation of duties, meeting the development requirements of the Company and to achieve the corporate governance enhancements. | |
| Extrawell Pharmaceutical Holdings Limited | 00858 | 05-Dec-13 | 04-Apr-18 | Ch | ||
| Extrawell Pharmaceutical Holdings Limited | 00858 | 11-Jun-01 | 02-Jul-12 | ED |